Precision Value & Health

What Precision Value & Health does

Precision Value & Health, now operating as Precision AQ, is a private healthcare consulting and commercialization firm headquartered in New York that serves pharmaceutical and biotechnology leaders across the full product lifecycle, from real-world data research and HEOR evidence generation through medical communications, market access, brand strategy, and investor relations. The firm operates as a multi-workstream Agency of Record, embedding cross-functional teams with clients on launches, label expansions, and ongoing commercialization programs, and reports coverage of every FDA-approved drug launch in 2024. It is part of the broader Precision Medicine Group, sharing operational infrastructure with sibling healthcare companies.

The firm's technology stack comprises five product modules: AccessGenius and OncoGenius for market potential evaluation (with OncoGenius focused on oncology), Data Solutions for patient, payer, and provider insights, EHR Solutions for health-system integration, and Omnichannel Solutions for multi-stakeholder engagement. These products are sold alongside core consulting services, but the firm does not publicly position any of them as AI-native platforms; AI/ML is not explicitly called out in product descriptions.

Precision AQ's business model is professional services-led, with quote-based, scope-tailored engagements sold through direct enterprise sales to pharma and biotech leadership. Therapeutic depth across Oncology, Neurology, Immunology, Rare Disease, and Cardio Renal Metabolic is the primary specialization axis, and international delivery is provided through Precision AQ International (UK). M&A has been used to extend capabilities, including acquisitions of Across Health (2021) for omnichannel engagement and Makara Health (2023) for international medical communications.

Name

Precision Value & Health

Legal name

Precision AQ

Website

https://precisionvaluehealth.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Precision AQ (formerly Precision Value & Health) is a private pharma and biotech commercialization consultancy delivering market access, HEOR, medical communications, investor relations, and brand strategy as an Agency of Record, supported by proprietary Data, EHR, and Omnichannel technology modules.

Ownership category

akta.pro rank

Product category

Pharmaceutical Market Access Consulting

NAICS

Other Scientific and Technical Consulting Services (54169)

akta.pro primary industry

Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE)

akta.pro secondary industry

Healthcare Master Data Management (MDM) & Patient/Provider Identity Data (HLACAIAB)

Keywords

• Pharmaceutical market access
• Health economics consulting
• Medical communications agency
• Biotech commercialization services
• HEOR evidence generation

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Consulting Services: Professional consulting services across value and access, HEOR, market access, medical communications, investor relations, and brand strategy marketing. Services are delivered to pharmaceutical and biotech companies throughout the commercialization journey.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Precision Value & Health (Precision AQ) is a healthcare consulting and solutions firm that helps pharmaceutical and biotech companies commercialize therapies through market access strategy, HEOR evidence generation, medical communications, investor relations, brand strategy, and proprietary data products. It combines consulting expertise with technology platforms (AccessGenius, OncoGenius, Data Solutions, EHR Solutions, Omnichannel Solutions) to support the full commercialization journey.

Product overview

Precision AQ is a unified platform offering that integrates technology, expertise, and strategy to help pharma and biotech leaders navigate market access and commercialization. The product portfolio includes AccessGenius and OncoGenius (specialized market potential evaluation tools), Data Solutions (patient, payer, and provider analytics), EHR Solutions (health system integration), and Omnichannel Solutions (multi-channel engagement). These products work together to transform data chaos into actionable insights, supporting the full commercialization journey from real-world data research to patient communications. The platform also encompasses service offerings in Value & Access, HEOR, Medical Communications, Brand Strategy & Marketing, Data Insights & Analytics, and Investor Relations.

Differentiator

Problem solved

Functional benefit

Products and services

• Value & Access Consulting service delivering HEOR evidence generation, payer strategy, and payer marketing to help pharma and biotech clients navigate payer complexity and secure market access for therapies.
• HEOR (Health Economics and Outcomes Research) Dedicated HEOR service producing real-world evidence and economic analyses to support payer strategy, reimbursement, and market access submissions for pharmaceutical products.
• Medical Communications Medical communications service encompassing peer-to-peer marketing, medical affairs support, and learning and development programs for pharmaceutical brand teams.
• Investor Relations & External Communications Service offering investor relations and public relations support tailored to biotech and pharma companies for financial community engagement and corporate visibility.
• Brand Strategy & Marketing Service line delivering brand strategy, advertising, data-driven insights, and learning and development to build brand identity and market presence for pharma clients.
• Data, Insights, & Analytics Analytics service providing patient, payer, and provider data-driven insights to inform market access and commercialization strategies.
• AccessGenius Proprietary product solution designed to evaluate market access potential and support commercial impact for healthcare products, enabling HCP, payer, and patient engagement.
• OncoGenius Specialized oncology product solution for evaluating market potential and supporting commercial impact, helping optimize patient access to cancer treatments.
• Data Solutions Data-driven product offering providing patient, payer, and provider insights to support market access and commercialization strategies.
• EHR Solutions Electronic Health Record product integrating with healthcare systems to support data-driven market access, provider targeting, and commercial impact.
• Omnichannel Solutions Multi-channel engagement product enabling HCP, payer, and patient outreach to streamline targeting and support commercial impact.

Quantifiable outcome

• 100% of all FDA-approved drugs in 2024 were launched with Precision AQ

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core and regional.

• Precision Medicine GroupcoreOthersPrecision AQ is part of the Precision Medicine Group, a parent organization that includes multiple healthcare-focused companies. The group provides shared infrastructure including HR, IT, and operational support. Precision AQ serves as one of the specialized subsidiaries focused on market access and commercialization services.
• Precision AQ InternationalregionalOthersInternational operations arm serving UK and global markets with localized market access consulting services. Website available at /en-gb/ for UK and international clients requiring regional expertise.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Trinity Life Sciences: Trinity Life Sciences is one of the closest direct competitors, providing market access, HEOR, and evidence-generation consulting to pharma and biotech — directly overlapping Precision AQ's Value & Access and HEOR offerings and competing for AOR relationships.
• Evidera (PPD/parent): Evidera provides HEOR, market access, and real-world evidence services to global pharma — a direct peer competing for the same evidence-generation and payer strategy engagements that Precision AQ delivers.
• Beghou Consulting: Beghou Consulting is a specialized life sciences consultancy focused on data-driven market access, commercialization, and analytics — directly comparable to Precision AQ's access consulting and data solutions practice.
• ZS Associates: ZS Associates is a global management consulting and analytics firm serving pharma with deep expertise in market access, sales/marketing analytics, and launch strategy — overlapping directly with Precision AQ's commercialization and data practices.
• Real Chemistry: Real Chemistry is a healthcare marketing, communications, and data firm serving pharma — directly comparable to Precision AQ's medical communications and brand strategy solutions.
• Avalere Health: Avalere Health provides market access, HEOR, and policy advisory services to pharma — directly competitive with Precision AQ's payer strategy and evidence-generation work.

Broad incumbents

• Huron Consulting Group (Life Sciences): Huron is a broad management consultancy with a sizable life sciences practice offering market access and commercialization services — overlapping with Precision AQ's offerings but as part of a much larger, diversified portfolio.
• Inizio: Inizio is a global pharma services platform combining market access (via subsidiaries like Putnam), medical communications, and commercialization — competing with Precision AQ across multiple solution areas within a diversified portfolio.
• Fishawack Health: Fishawack Health is a global commercialization and medical communications group serving pharma — directly comparable to Precision AQ's medical communications and brand strategy solutions but operating as part of a broader medical agency platform.
• Charles River Associates (Life Sciences): CRA's Life Sciences practice provides consulting in HEOR, pricing, market access, and commercial strategy for pharma — comparable to Precision AQ's Value & Access and HEOR offerings within a larger diversified economics and consulting firm.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/precision-aq

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precision Value & Health